Lexington, KY, United States of America

Amanda J Sherratt

This inventor holds 1 USPTO granted patent. Top assignee: Theramax Inc.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amanda J Sherratt. Retrieved from https://idiyas.com/inventor/amanda-j-sherratt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Amanda J Sherratt: Innovator in Pharmaceutical Delivery Systems

Introduction

Amanda J Sherratt is a notable inventor based in Lexington, KY (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the delivery of medications. Her innovative approach focuses on enhancing the systemic delivery of drugs through alternative administration routes.

Latest Patents

Amanda holds a patent for a method titled "Method for enhanced delivery of oxybutynin and compositions thereof." This invention provides a method for the enhancement of systemic delivery of oxybutynin by administration via the nasal route. The patent also includes methods of treatment that comprise intranasal administration of oxybutynin. Furthermore, it presents pharmaceutical compositions that include oxybutynin and/or pharmaceutically acceptable salts thereof. Amanda has 1 patent to her name.

Career Highlights

Amanda is currently associated with Theramax Inc., where she continues to work on innovative solutions in drug delivery. Her expertise in pharmaceutical formulations has positioned her as a valuable asset in her field.

Collaborations

Amanda collaborates with Abdulghan A Houdi, contributing to advancements in their shared research interests.

Conclusion

Amanda J Sherratt's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her contributions to drug delivery systems are paving the way for more effective treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…